Astaxanthin: what the research shows and what it doesn't

Astaxanthin is the red-orange pigment that gives some seafood its colour, and it now also comes as a capsule linked to skin, sport, screens and brain. Is any of that backed by human studies? Here is the lobster-red backstory: what astaxanthin is, what people have actually been tested on, and where the evidence thins out.

In brief, the best-supported findings are modest and specific. Oral astaxanthin improved some skin moisture and elasticity measures in small trials, and a 2026 review found hints of a recovery effect after exercise but no clear performance gain. Eye, brain and "inflammation" results are early, often small and often funded by the people who sell the ingredient. It is an interesting carotenoid with a reasonable safety record at the doses the EU allows in supplements, and none of those outcomes is firmly established yet.

What astaxanthin is

Astaxanthin is a carotenoid, the pigment family that also includes beta-carotene and lutein. It is found in fish and crustaceans in the diet, and the main supplement source is a microalga, Haematococcus pluvialis. Synthetic astaxanthin also exists: EFSA, the EU food-safety agency, discusses it in its toxicity data and notes that a colouring form is used as a feed additive for farmed fish (EFSA NDA Panel, 2020, EFSA Journal).

Supplements are not all the same material. EFSA's 2025 opinions describe two H. pluvialis ingredients: an oleoresin made by supercritical CO2 extraction of dried algal biomass, containing roughly 10% astaxanthin by weight, and an algal meal made by crushing and spray-drying the biomass, containing roughly 5% (EFSA, 2025, oleoresin extension of use; EFSA, 2025, algal meal). The milligrams on the label, not the milligrams of algae, are what you compare.

Two practical points about how your body handles it:

• It is fat-soluble. In a small human study, 32 healthy men took a single 40 mg dose either as a commercial supplement or in one of three laboratory lipid-based formulations. The lipid formulations delivered 1.7 to 3.7 times more astaxanthin into the blood, and the half-life was around 16 hours (Mercke Odeberg et al., 2003, European Journal of Pharmaceutical Sciences). That trial tested surfactant and lipid formulations, not retail capsules or meals, but it fits with the usual advice to take astaxanthin with food.
• A test-tube result is not a human result. Laboratory antioxidant assays tell you what a molecule does in a dish. How well they predict an outcome in a person is exactly what the trials below try to find out. Our reading: so far the answer is "sometimes, a little".

What human studies show, outcome by outcome

• Outcome: Skin; Best human evidence: 2021 systematic review and meta-analysis, nine oral randomised trials; What it showed: Better moisture and elasticity than placebo; no clear change in wrinkle depth; Main caveat: Small trials (16 to 65 people), some commercially funded
• Outcome: Exercise; Best human evidence: 2026 review of 24 randomised trials (12 to 13 pooled per outcome; 8 for creatine kinase); What it showed: Lower creatine kinase; no clear gain in VO2max, time trials or power; Main caveat: Varied protocols; an earlier analysis disagreed on performance
• Outcome: Eyes and screens; Best human evidence: A handful of randomised trials; What it showed: Some measures of visual function or eye strain improved; Main caveat: Small, short, often industry-sponsored, several used blends
• Outcome: Cognition; Best human evidence: 2024 meta-analysis and 2024 critical review; What it showed: Mixed: marginal accuracy effect, no reaction-time effect; Main caveat: Healthy volunteers, small trials, tests that may not suit them
• Outcome: Inflammation and oxidative stress markers; Best human evidence: 2026 meta-analysis (exercise) and a 2026 systematic review; What it showed: One oxidative marker fell; other markers did not change; Main caveat: Surrogate markers, mixed populations

Skin: the best-supported area, with limits

A 2021 systematic review pooled nine randomised trials of oral astaxanthin. Compared with placebo, it found better skin moisture (standardised mean difference 0.53, 95% CI 0.05 to 1.01) and elasticity (0.77, 95% CI 0.19 to 1.35), but no significant effect on wrinkle depth. The trials ran for 4 to 16 weeks, mostly at 4 to 12 mg a day, with 16 to 65 participants each. The authors noted that several trials were run or funded by commercial entities, and that this made it hard to judge how much bias there was (Zhou et al., 2021, Nutrients).

One of those trials gave 4 mg a day for 10 weeks to 23 healthy Japanese adults. The astaxanthin group needed more UV to redden the skin (a higher minimal erythema dose) and lost less moisture in irradiated skin than placebo. The authors worked for Fujifilm, which funded the study (Ito et al., 2018, Nutrients). That is interesting, and it is not a sunscreen. Keep wearing one.

Exercise: recovery, perhaps, performance, not clearly

The newest and largest review included 24 randomised trials of oral astaxanthin in healthy people and athletes, with doses from 4 to 28 mg a day for 4 days to 16 weeks. Not every trial fed every analysis: 12 contributed to the performance pooling and 13 to recovery, and creatine kinase came from eight comparisons. It found lower creatine kinase (a marker of muscle damage; SMD -0.45, 95% CI -0.83 to -0.07) and lower lactate dehydrogenase (-0.93, 95% CI -1.39 to -0.48, but with substantial heterogeneity, so the authors urge caution). It found no significant effect on VO2max, time-trial performance or maximal power, and none on malondialdehyde or interleukin-6 (Liu et al., 2026, Nutrients).

An earlier 2024 meta-analysis of 11 trials in 346 healthy participants did report better physical performance (SMD 0.62) and fat oxidation, especially with aerobic exercise, higher doses and longer supplementation (Liu et al., 2024, Biological Research for Nursing). The two analyses used different trial sets and outcomes, which is probably why they disagree. Another 2026 meta-analysis of seven trials (188 participants) found astaxanthin lowered one marker of protein oxidation (AOPP) but not several others, and concluded that broader benefits remain unconfirmed (You et al., 2026, 3 Biotech).

Single trials can look dramatic and still be tiny. A 2025 trial in ten active young men gave 28 mg a day for four days and reported a longer time to exhaustion on a bike (Tsao et al., 2025, BMC Sports Science, Medicine and Rehabilitation). That is an interesting signal, from ten people, at 3.5 times the 8 mg a day the EU authorises for supplements.

Eyes and screens: early signals, plenty of sponsors

Screens are where astaxanthin marketing gets specific, so it's worth seeing what was measured. Several Japanese trials looked at visual-display work. In 60 healthy adults, a diet containing 9 mg a day of astaxanthin for six weeks protected corrected visual acuity of the dominant eye after screen work, but only in people aged 40 and over, and not in the other measures; the trial was sponsored by BGG Japan and its authors included company employees (Sekikawa et al., 2023, Journal of Clinical Biochemistry and Nutrition). Others tested blends, such as astaxanthin with lutein and zeaxanthin (Yoshida et al., 2023, Nutrients) or with anthocyanin and lutein (Kizawa et al., 2021, Journal of Clinical Biochemistry and Nutrition). A blend can't tell you what the astaxanthin did.

A 2025 trial in 64 children aged 10 to 14 with screen-related eye strain reported symptom improvements after 84 days; several of its authors work for the makers of the branded ingredient tested (Hecht et al., 2025, Advances in Therapy). These studies measure visual function and eye-strain symptoms after screen work; none tested gaming performance, so they can't be stretched into one.

Brain and thinking

A 2024 meta-analysis found only a marginal effect of astaxanthin on cognitive accuracy (SMD 0.12, 95% CI -0.02 to 0.26) and none on reaction time, in healthy volunteers (Liu et al., 2024). A 2024 critical review reported benefits for some aspects of memory and response time and none for others, and pointed out that the most-used test, CogHealth, was designed for people with no or mild cognitive impairment, so findings in healthy volunteers could be less valid because the test is "non-specific" and "comparatively easier" for people without impairment. It also noted that blended products make results hard to attribute. The reviewers still highlighted positive findings in some contexts, while calling for better-designed trials (Queen et al., 2024, Nutrients). For now it's an open question rather than a focus supplement.

Inflammation and general antioxidant claims

A 2026 systematic review of 15 human studies reported lower inflammatory cytokines and oxidative stress indices across very different populations, including people with PCOS or endometriosis, and called for better trials (Malcangi et al., 2026, International Journal of Molecular Sciences). The exercise meta-analyses above found IL-6 unchanged. Lower marker levels are not the same as feeling or functioning better.

Safety, doses and who should ask first

An 8-week trial in 35 healthy adults taking 6 mg of astaxanthin a day from a H. pluvialis extract found no clinically important differences in blood pressure or blood chemistry against placebo (Spiller and Dewell, 2003, Journal of Medicinal Food). EFSA's 2020 opinion concluded that 8 mg a day from supplements, added to the astaxanthin people already get from fish and crustaceans, is safe for adults. It also found that adolescents aged 14 to under 18 would reach the acceptable daily intake (0.2 mg per kg of body weight), and that the intake would exceed it by 28% in children aged 10 to under 14 and by up to 524% in infants aged 4 to 6 months (EFSA NDA Panel, 2020).

No source cited here tells pregnant or breastfeeding readers what is safe, so they should ask a clinician or pharmacist first. The same goes for anyone on regular medication. Our interaction guide covers keeping a precise product list for that conversation.

EU and Dutch position (read on 8 October 2026)

In the EU, astaxanthin-rich oleoresin from H. pluvialis is an authorised novel food for supplements. EFSA's 2025 opinion summarises the position: the original Union list entry allowed 40 to 80 mg of oleoresin a day, equal to up to 8 mg astaxanthin; a 2021 amendment added a label statement that supplements should not be consumed by children under 14; and a 2023 amendment allowed up to 2.3 mg a day for children aged 3 to under 10 and up to 5.7 mg for ages 10 to under 14, with a statement that supplements are not for children under 3 (EFSA, 2025).

The same agency's 2025 opinions looked at adding the oleoresin and the algal meal to dairy alternatives and fruit juices. They concluded those uses would be safe provided children and adolescents do not also take an astaxanthin supplement on the same day (EFSA, 2025, oleoresin; EFSA, 2025, algal meal). Whether the Commission has acted on them isn't covered here. EU novel-food rules apply in the Netherlands as in other member states, and the figures above are as EFSA describes the Union list; rules change, so check the current entry before relying on them. The position of whole-algae-meal supplements is less clear, so the exact ingredient named on the label matters.

Five things to check on the pack

Here is what to compare, in order of usefulness:

1. Milligrams of astaxanthin per serving, not milligrams of extract or algae. Compare it with the 4 to 12 mg range most skin trials used.
2. Source and form. Algae-derived and synthetic astaxanthin are different materials, and an oleoresin and an algal meal differ in concentration.
3. Carrier and instructions. Most are oil-based softgels with advice to take them with food, which fits the fat-solubility point above. A better-looking carrier does not prove better absorption.
4. What the claim is about. "Supports skin" on a pack is not the same as the trial outcome above.
5. Testing information. A lab result for one sample is information about that sample.

One supplier example

PLNKTN's public astaxanthin page (read on 8 October 2026) describes a softgel with 8 mg astaxanthin from Haematococcus pluvialis grown in Belgium, with MCT oil, natural vitamin E and a plant-based capsule, to be taken once a day during or after a meal, and shows a lab-results panel for one sample. The page says "Tegen vrije radicalen" (against free radicals) with a footnote, beside the description of the vitamin E it adds. This is supplier information, not our measurement. One capsule a day gives the same 8 mg as the EU adult ceiling discussed above, so the label of any second astaxanthin product matters.

So, is astaxanthin worth being curious about?

Yes, with realistic expectations. The skin findings are the most consistent, the exercise findings lean towards recovery rather than speed, and the eye and brain findings are early. If you are comparing products, match the dose and form to what was studied and expect a modest effect at best. For a method that works on any pack, see our supplement label guide.

Where to read next

Astaxanthin has algae neighbours worth knowing about:

• Omega-3: EPA, DHA, fish and algae, for how to read EPA and DHA and how fish, krill and algae oils differ.
• Spirulina and chlorella: what is the difference?, for a cyanobacterium versus a green alga, the evidence, safety and EU status.

Written by Smart Supplements with AI assistance from the sources linked in the text. It has not been reviewed by a clinician.

Last updated: 12 October 2026

This article is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before starting any new supplement, especially if you take prescription medication.